Collectively, our data implicate autocrine C3a-C3aR signaling in metabolic reprogramming of microglia to neuroprotective DAM during aging, especially in females, and also in Alzheimer’s Disease. This evidence concerns the gene C3 and early-onset autosomal dominant Alzheimer disease.